HPV Education, Early Diagnosis and Knowledge

June 13, 2024 updated by: Nurten Terkes, Mehmet Akif Ersoy University

The Effect of HPV Training on Early Diagnosis Screening and Knowledge Levels of Female Teachers

The aim of this study was to determine the effect of health education given to female teachers on HPV knowledge and screening test. The population of the study consisted of all female teachers belonging to the Bucak Directorate of National Education between September 2021 and March 2022. The sample of the study consisted of 144 healthy female teachers who were registered in the institutions affiliated to the District Directorate of National Education between the specified dates, met the inclusion criteria and volunteered to participate in the study. In this study area, with the assumption that the rate of cervical cancer screening test of 70% of the women in the Healthy Life Centre after the trainings would be considered significant, the effect size d=0.18 was calculated to include at least 98 women in 3 groups at 95% power and 0.05 error level. The calculation was performed with the 'G Power 3.1.9.2' package programme. In this context, the total sample of the study was determined as 156 participants, 52 in each group.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

156

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Bucak
      • Burdur, Bucak, Turkey, 15000
        • Burdur Mehmet Akif Ersoy University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • to volunteer to participate in the study,
  • To be between the ages of 30-65,
  • being a woman teacher,
  • being married
  • to be able to make video calls.

Exclusion Criteria:

  • being pregnant or in the postnatal period,
  • a history of cervical cancer,
  • to have hysterectomy operation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Face to face education
In addition to the standard cervical cancer screening programme service, participants in this group received individual face-to-face health education on HPV and cervical cancer prevention through home visits and were given educational brochures. Participants in this group were interviewed a total of four times (four times face-to-face) during the research process.
Behavioral: Face to face education
In addition to the standard cervical cancer screening programme service, participants in this group received individual face-to-face health education on HPV and cervical cancer prevention through home visits and were given educational brochures. Participants in this group were interviewed a total of four times (four times face-to-face) during the research period.
Experimental: Online education
In addition to the standard cervical cancer screening programme service, participants in this group received individual health education on HPV and cervical cancer prevention online via video call via WhatsApp application and were given a digital education brochure. Participants in this group were interviewed a total of four times (four times remotely) during the research process.
Behavioral: Online education
In addition to the standard cervical cancer screening programme service, participants in this group received individual health education on HPV and cervical cancer prevention online via video call via WhatsApp application and were given a digital education brochure. Participants in this group were interviewed a total of four times (four times remotely) during the research process.
No Intervention: Control
During the research process, the participants in the control group did not receive any intervention other than the standard cervical cancer screening programme service. During the research process, the participants in the control group were interviewed face-to-face twice. After the termination of the study, health education on protection against HPV and cervical cancer was provided to the volunteer participants by a method they specified and an educational brochure was given.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Human Papilloma Virus (HPV) Knowledge Scale:
Time Frame: 5-10 minutes
HPV Knowledge Scale is a knowledge test developed by Waller et al. (2013) to determine the level of knowledge of individuals about HPV agent, HPV screening tests and vaccine. The scale, whose Turkish validity and reliability was conducted by Demir and Özdemir in 2019, has a total of 33 items. The HPV Knowledge Scale consists of four sub-dimensions: general HPV knowledge (items 1-16), HPV screening test knowledge (items 17-22), general HPV vaccine knowledge (items 23-27) and knowledge of the current HPV vaccination programme (items 28-33).
5-10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mehmet Akif Ersoy University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2021

Primary Completion (Actual)

February 10, 2022

Study Completion (Actual)

March 14, 2022

Study Registration Dates

First Submitted

June 10, 2024

First Submitted That Met QC Criteria

June 13, 2024

First Posted (Actual)

June 18, 2024

Study Record Updates

Last Update Posted (Actual)

June 18, 2024

Last Update Submitted That Met QC Criteria

June 13, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • GO 2020/71)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

All authors contributed to the interpretation, writing, and approval of the final manuscript.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Female Teachers

Clinical Trials on Face to face education

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe